About Us
Since 2005, our philosophy has been supported by growth in new and improved therapies with innovative branded products. On the basis of the import of low-priced original preparations from EU member states, considerable savings potential can be realised in drug expenditure. In Germany, parallel import, which uses price competition without quality differences, has been established since the 1970s and saves around 222 million euros annually for statutory health insurance companies. In Austria, the market for original EU medicines is still relatively young. In this market, however, health insurance companies are saving part of their expenses with our original drugs, especially in the high-priced therapeutic areas.
In constant cooperation with doctors and pharmacists, over 240 million euros are saved annually on prescription and dispensing. In this way, we make an important contribution to ensuring a cost-conscious supply of medicines.
Permanent increase in value
Our healthy growth proves that our product philosophy and implementation are widely recognized. On this foundation we are constantly setting ourselves new goals to meet the growing demands of society and to look confidently towards a transparent health system.
HAEMATO PHARM GmbH
Lilienthalstraße 5c
D-12529 Schönefeld
Your contact in Germany
Phone: +49-30-677 98 67 600
Telefax: +49-30-677 98 67 707
service@haemato.de
Your contact in Austria
Phone: 0800 293 527
Telefax: 0800 296 426
service@haemato.at
HAEMATO Group